The Importance of Biocompatibility in Peritoneal Dialysis Solutions

Duwe A.K. , Vas S.I. , Weatherhead J.W. Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis, and bactericidal activity in vitro. Infect Immun 1981; 33: 130–5.

Dobbie J.W. , Lloyd J.K. , Gall C.A. Categorization of ultrastructural changes in peritoneal mesothelium, stroma and blood vessels in uremia and CAPD patients. Adv Perit Dial 1990; 6: 3–12.

Gotloib L. , Shostak A. Peritoneal ultrastructure. In: Nolph K.D. , ed. Peritoneal dialysis. Dordrecht: Kluwer Academic, 1989: 67–95.

Gotloib L. , Bar-Sella P. , Shostak A. Reduplicated basal lamina of small venules and mesothelium of human parietal peritoneum: Ultrastructural changes of reduplicated peritoneal basement membrane. Perit Dial Bull 1985; 212–5.

Blake P.G. , Abraham G. Sombolos K, et al. Changes in peritoneal membrane transport rates in patients on long-term CAPD. Adv Perit Dial 1989; 5: 3–7.

Breborowicz A. , Rodela H. , Pagiamtzis J. , Diamandis E. , Oreopoulos D.G. Glucose (G) toxicity to human meso thelial cells (MC) in vitro. Perit Dial Int 1990; 10(Suppl 1): 19.

Van Bronswijk H. , Verbrugh H.A. , Bos H.J. Cytotoxic effects of commercial continuous ambulatory peritoneal dialysis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro. Perit Dial Int 1989; 9: 197–202.

Topley N. , Mackenzie R. , Petersen M.M. In vitro testing of a potentially biocompatible continuous ambulatory peritoneal dialysis fluid. Nephrol Dial Transplant 1991; 6: 574–81.

De Fijter C.W.H. , Verbrugh H.A. Immunological response to different peritoneal dialysis solutions and schedules. In: Laareca A. , Ronco C. , Feriani M. , Chiaramonte S. , Conz P. ., eds. Peritoneal dialysis. Milano: Wichtig, 1991: 179–84.

Jörres A. , Jörres D. , Gahl G.M. Leukotriene B4 and tumor necrosis factor release from leukocytes: Effect of peritoneal dialysate. Nephron 1991; 58: 276–82.

Steinhauer H.B. , Brugger U. , Lubrich-Birkner I. , Schollmeyer O. Effect of CAPD dialysate on the release of prostanoids and cytokines from peritoneal macrophages (PMO). Perit Dial Int 1992; 12(Suppl 1): 163.

De Fijter C.W.H. , Oe P.L. , Verbrugh H.A. Glucose polymers as osmotic agent in CAPD fluids: A more favorable effect on peritoneal macrophage (PMO) function than glucose-based solutions. Kidney Int 1991; 40: 978.

Jörres A. , Gahl G.M. , Mülier C. , Passlick-Deetjen J. In vitro biocompatibility testing of a new glucose polymer dialysis fluid for CAPD. Nephrol DialTransplant 1992; 7: 774.

Topley N. , Alobaidi H.M.M. , Davies M. , Coles G.A. , Williams J.D. , Lloyd D. The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int 1988; 34: 404–11.

Jörres A. , Gahl G.M. , Ludat K. , Müller C. , Passlick Deetjen J. In vitro biocompatibility testing of a new bicarbonate-buffered dialysis fluid for CAPD. Perit Dial Int 1992; 12(Suppl 2): 826.

Di Paolo N. Behaviour of mesothelial cells in culture in the presence of bicarbonate and lactate. Presentation at the VIth International Congress of the 18PD, Thessaloniki, Greece, 1992.

Feriani M. , Dissegna C. , Laareca A , Passlick-Deetjen J. Continuous ambulatory peritoneal dialysis with bicarbonate buffer -a pilot study. Presentation at the VIth International Congress of the 18PD, Thessaloniki, Greece, 1992.

Twardowski Z.J. , Nolph K.D. , Khanna R. , Prowant B. Peritoneal equilibration test. Perit Dial Bull 1987; 7: 138–47.